FMP
Anebulo Pharmaceuticals, Inc.
ANEB
NASDAQ
Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing and commercializing treatments for people suffering from acute cannabinoid intoxication and substance addiction. Its lead product candidate is ANEB-001, a small molecule cannabinoid receptor antagonist to treat cannabinoid intoxication and overdose. The company was incorporated in 2020 and is based in Lakeway, Texas.
2.78 USD
0.03 (1.08%)
About
ceo
Mr. Richard Anthony Cunningham
sector
Healthcare
industry
Biotechnology
website
https://www.anebulo.com
exchange
NASDAQ
Description
Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing and commercializing treatments for people suffering from acute cannabinoid intoxication and substance addiction. Its lead product candidate is ANEB-001, a small molecule cannabinoid receptor antagonist to treat cannabinoid intoxication and overdose. The company was incorporated in 2020 and is based in Lakeway, Texas.
CIK
0001815974
ISIN
US0345691036
CUSIP
034569103
Address
1415 Ranch Road 620 South
Phone
512 598 0931
Country
US
Employee
2
IPO Date
May 7, 2021
Summary
CIK
0001815974
Exchange
NASDAQ
Industry
Biotechnology
Sector
Healthcare
CUSIP
034569103
ISIN
US0345691036
Country
US
Price
2.78
Beta
-1
Volume Avg.
5.68k
Market Cap
72.09M
Shares
-
52-Week
1.62-4.05
DCF
0.45
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-6.78
P/B
-
Website
https://www.anebulo.com
Historical Prices
We are unable to load the chart at this time.
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
Upgrades and Downgrades
We are unable to load this data!
People Also Watch
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest ANEB News
It looks like there's no news available.
